Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Novartis AG Common Stock
(NY:
NVS
)
145.11
+1.53 (+1.07%)
Official Closing Price
Updated: 4:10 PM EST, Jan 21, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,027,184
Open
143.82
Bid (Size)
143.60 (100)
Ask (Size)
147.25 (100)
Prev. Close
143.58
Today's Range
143.43 - 145.22
52wk Range
97.72 - 146.35
Shares Outstanding
N/A
Dividend Yield
2.75%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
GSK Challenges Xolair Dominance with $2.2 Billion Acquisition of RAPT Therapeutics
January 20, 2026
In a bold strategic opening to the 2026 fiscal year, pharmaceutical giant GSK (NYSE:GSK) has announced a definitive agreement to acquire RAPT Therapeutics (Nasdaq:RAPT) for approximately $2.2 billion....
Via
MarketMinute
Topics
Intellectual Property
Novartis AG-Sponsored ADR (NYSE:NVS) Presents a Compelling Value Investment Case
↗
January 20, 2026
Via
Chartmill
Performance
YTD
+4.7%
+4.7%
1 Month
+6.0%
+6.0%
3 Month
+10.5%
+10.5%
6 Month
+24.2%
+24.2%
1 Year
+45.5%
+45.5%
More News
Read More
Silicon Meets Science: NVIDIA and Eli Lilly Launch $1 Billion AI Lab to Engineer the Future of Medicine
January 19, 2026
Via
TokenRing AI
Topics
Artificial Intelligence
International Exposure: SPDW's Lower Costs vs. URTH's U.S. Giants
↗
January 17, 2026
Via
The Motley Fool
Topics
ETFs
The Atomic Revolution: How AlphaFold 3 is Redefining the Future of Medicine
January 16, 2026
Via
TokenRing AI
Topics
Artificial Intelligence
NVS Stock Rises After FDA Grants Breakthrough Therapy Designation For Autoimmune Disorder Treatment
↗
January 16, 2026
Via
Stocktwits
The Atomic Revolution: How AlphaFold 3’s Open-Source Pivot Has Redefined Global Drug Discovery in 2026
January 15, 2026
Via
TokenRing AI
Topics
Artificial Intelligence
Derivatives
Economy
The Silicon Laureates: How the 2024 Nobel Prizes Cemented AI as the New Language of Science
January 15, 2026
Via
TokenRing AI
Topics
Artificial Intelligence
IEFA vs. SPDW: Broad International Exposure With Different Portfolio Designs
↗
January 14, 2026
Via
The Motley Fool
Topics
ETFs
The Silicon Laureates: How 2024’s ‘Nobel Prize Moment’ Rewrote the Laws of Scientific Discovery
January 14, 2026
Via
TokenRing AI
Topics
Artificial Intelligence
Electric Vehicles
The Digital Microscope: How AlphaFold 3 is Decoding the Molecular Language of Life
January 14, 2026
Via
TokenRing AI
Topics
Artificial Intelligence
Bonds
SLS Stock In Spotlight On EU Expansion For Cancer Therapy – Retail Says Potential Catalyst For Buyout
↗
January 14, 2026
Via
Stocktwits
Viatris Inc. (NASDAQ: VTRS): Navigating the Pivot from Integration to Innovation
January 14, 2026
Via
Finterra
Topics
Earnings
Economy
Intellectual Property
Travere Therapeutics Shares Fall After FDA Extends Filspari Review for FSGS
January 13, 2026
Via
MarketMinute
Amgen at the Crossroads: MariTide, Market Volatility, and the Quest for Obesity Dominance
January 13, 2026
Via
PredictStreet
Topics
Economy
Intellectual Property
The Evolution of a Giant: A Deep Dive into the ‘New’ Johnson & Johnson (JNJ) in 2026
January 13, 2026
Via
PredictStreet
Topics
Artificial Intelligence
Bankruptcy
Economy
Why Tempus AI Stock Rose Today
↗
January 12, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Beyond the Protein: How AlphaFold 3 Redefined the Blueprint of Life and Accelerated the Drug Discovery Revolution
January 12, 2026
Via
TokenRing AI
Topics
Artificial Intelligence
Is Novartis AG Gaining or Losing Market Support?
↗
January 12, 2026
Via
Benzinga
3 Dividend Stocks to Buy in 2026 and Hold Forever
↗
January 11, 2026
Via
The Motley Fool
MoonLake Immunotherapeutics Surges as FDA "De-Risks" Sonelokimab, Reigniting Multi-Billion Dollar Takeover Speculation
January 09, 2026
Via
MarketMinute
Topics
Intellectual Property
BioNTech Finalizes CureVac Acquisition: A Strategic Consolidation Met with Market Skepticism
January 09, 2026
Via
MarketMinute
Topics
Intellectual Property
J&J Cuts Deal With Trump’s White House To Slash Drug Prices And Dodge Tariffs
↗
January 08, 2026
Via
Stocktwits
Topics
Government
Trade War 2.0: Markets Braced as Trump’s 2026 Tariff ‘Salvos’ Reshape the Global Supply Chain
January 08, 2026
Via
MarketMinute
Topics
Economy
Government
World Trade
New Investors: 3 Stocks to Build Your Portfolio Around in 2026
↗
January 08, 2026
Via
The Motley Fool
Frequently Asked Questions
Is Novartis AG Common Stock publicly traded?
Yes, Novartis AG Common Stock is publicly traded.
What exchange does Novartis AG Common Stock trade on?
Novartis AG Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novartis AG Common Stock?
The ticker symbol for Novartis AG Common Stock is NVS on the New York Stock Exchange
What is the current price of Novartis AG Common Stock?
The current price of Novartis AG Common Stock is 145.11
When was Novartis AG Common Stock last traded?
The last trade of Novartis AG Common Stock was at 01/21/26 04:10 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.